M2i Life Sciences raises 60 mln euros

M2i Life Sciences raised 60 million euros ($65.6 million) in funding led by ADM Capital Europe. M2i produces pheromones to that aim to sustainably and economically replace chemical pesticides in agriculture, parks and gardens. ADM Capital will have a minority of M2i.

3 September 2019•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail